網絡安全板塊現漲停潮 工信部稱到2023年產業規模超2500億
格隆匯7月12日丨網絡安全板塊全線爆發,板塊指數大漲超7%。個股中,兆日科技和任子行漲20%封漲停板,迪普科技、綠盟科技、美亞柏科、奇安信、藍盾股份等均漲超10%,啟明星辰、衞士通和國華網安漲10%漲停,三六零漲超5%,寶信軟件和浪潮信息漲超3%。國家網信辦發文提出,掌握超過100萬用户個人信息的運營者赴國外上市,必須向網絡安全審查辦公室申報網絡安全審查。此外,工信部公開徵求對《網絡安全產業高質量發展三年行動計劃(2021-2023年)(徵求意見稿)》的意見提出,到2023年,網絡安全產業規模超過2500億元,年複合增長率超過15%。一批網絡安全關鍵核心技術實現突破,達到先進水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.